BR112014028395A2 - derivados 3,4-di-hidro-2h-pirido[1,2-a] pirazina-1,6-diona substituídos úteis para o tratamento de (inter alia) doença de alzheimer - Google Patents
derivados 3,4-di-hidro-2h-pirido[1,2-a] pirazina-1,6-diona substituídos úteis para o tratamento de (inter alia) doença de alzheimerInfo
- Publication number
- BR112014028395A2 BR112014028395A2 BR112014028395A BR112014028395A BR112014028395A2 BR 112014028395 A2 BR112014028395 A2 BR 112014028395A2 BR 112014028395 A BR112014028395 A BR 112014028395A BR 112014028395 A BR112014028395 A BR 112014028395A BR 112014028395 A2 BR112014028395 A2 BR 112014028395A2
- Authority
- BR
- Brazil
- Prior art keywords
- pyrido
- pyrazine
- alzheimer
- dihydro
- disease
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12168186 | 2012-05-16 | ||
EP12168186.0 | 2012-05-16 | ||
EP12195875 | 2012-12-06 | ||
EP12195875.5 | 2012-12-06 | ||
EP12197010.7 | 2012-12-13 | ||
EP12197010 | 2012-12-13 | ||
EP13159178.6 | 2013-03-14 | ||
EP13159178 | 2013-03-14 | ||
PCT/IB2013/054014 WO2013171712A1 (en) | 2012-05-16 | 2013-05-16 | Substituted 3, 4 - dihydro - 2h - pyrido [1, 2 -a] pyrazine - 1, 6 - dione derivatives useful for the treatment of (inter alia) alzheimer's disease |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112014028395A2 true BR112014028395A2 (pt) | 2017-06-27 |
BR112014028395B1 BR112014028395B1 (pt) | 2022-02-01 |
Family
ID=48670031
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112014028395-8A BR112014028395B1 (pt) | 2012-05-16 | 2013-05-16 | Derivados 3,4-di-hidro-2h-pirido[1,2-a]pirazina-1,6-diona substituídos úteis para o tratamento de (inter alia) doença de alzheimer e composição farmacêutica que os compreende |
Country Status (16)
Country | Link |
---|---|
US (1) | US9181245B2 (pt) |
EP (1) | EP2850083B1 (pt) |
JP (1) | JP6106745B2 (pt) |
KR (1) | KR102096625B1 (pt) |
CN (1) | CN104583208B (pt) |
AU (1) | AU2013261023B2 (pt) |
BR (1) | BR112014028395B1 (pt) |
CA (1) | CA2870347C (pt) |
EA (1) | EA027242B1 (pt) |
ES (1) | ES2585009T3 (pt) |
HK (1) | HK1207645A1 (pt) |
IL (1) | IL235659A (pt) |
MX (1) | MX355164B (pt) |
NZ (1) | NZ702611A (pt) |
SG (1) | SG11201407051XA (pt) |
WO (1) | WO2013171712A1 (pt) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2602794T3 (es) | 2011-03-31 | 2017-02-22 | Pfizer Inc | Piridinonas bicíclicas novedosas |
JP6106745B2 (ja) * | 2012-05-16 | 2017-04-05 | ヤンセン ファーマシューティカルズ,インコーポレーテッド | (特に)アルツハイマー病の治療に有用な置換3,4−ジヒドロ−2H−ピリド[1,2−a]ピラジン−1,6−ジオン誘導体 |
TWI603682B (zh) | 2012-05-31 | 2017-11-01 | 菲利浦莫里斯製品股份有限公司 | 用於氣溶膠產生物品之功能性桿 |
UA110688C2 (uk) * | 2012-09-21 | 2016-01-25 | Пфайзер Інк. | Біциклічні піридинони |
US10112943B2 (en) | 2012-12-20 | 2018-10-30 | Janssen Pharmaceutica Nv | Substituted imidazoles as gamma secretase modulators |
AU2014206834B2 (en) * | 2013-01-17 | 2017-06-22 | Janssen Pharmaceutica Nv | Novel substituted pyrido-piperazinone derivatives as gamma secretase modulators |
US20160229847A1 (en) * | 2013-10-04 | 2016-08-11 | Pfizer Inc. | Novel bicyclic pyridinones as gamma-secretase modulators |
JP6425717B2 (ja) * | 2013-10-04 | 2018-11-21 | ファイザー・インク | ガンマセクレターゼモジュレーターとしての新規二環式ピリジノン |
US10562897B2 (en) | 2014-01-16 | 2020-02-18 | Janssen Pharmaceutica Nv | Substituted 3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,6-diones as gamma secretase modulators |
AP2016009465A0 (en) * | 2014-04-01 | 2016-09-30 | Pfizer | Chromene and 1,1 a,2,7b-tetrahydrocyclopropa[c]chromene pyridopyrazinediones as gamma-secretase modulators |
JP6628805B2 (ja) * | 2015-02-03 | 2020-01-15 | ファイザー・インク | 新規シクロプロパベンゾフラニルピリドピラジンジオン |
CN105806830B (zh) * | 2015-12-10 | 2019-01-29 | 北京联众泰克科技有限公司 | 一种稳定的hrp酶促化学发光底物液、其制备方法及应用 |
CN108424382B (zh) * | 2018-02-27 | 2022-04-22 | 广东医科大学 | 一种3,3’-双取代联吡啶衍生物及其制备方法和应用 |
US20210267203A1 (en) | 2018-06-29 | 2021-09-02 | Syngenta Participations Ag | Pesticidally active azole-amide compounds |
UY38367A (es) * | 2018-09-13 | 2020-04-30 | Syngenta Participations Ag | Compuestos de azol-amida pesticidamente activos |
CN109574884A (zh) * | 2018-12-26 | 2019-04-05 | 淮安国瑞化工有限公司 | 一种2-(2,2-二氟乙氧基)-6-三氟甲基苯基丙基硫醚的制备方法 |
EP3696175A1 (en) | 2019-02-18 | 2020-08-19 | Syngenta Crop Protection AG | Pesticidally active azole-amide compounds |
WO2020188014A1 (en) | 2019-03-20 | 2020-09-24 | Syngenta Crop Protection Ag | Pesticidally active azole amide compounds |
CA3131861A1 (en) | 2019-04-11 | 2020-10-15 | Jurgen Harry Schaetzer | Pesticidally active diazine-amide compounds |
TW202126649A (zh) | 2019-09-26 | 2021-07-16 | 瑞士商諾華公司 | 抗病毒吡唑并吡啶酮化合物 |
WO2023159148A2 (en) * | 2022-02-18 | 2023-08-24 | Ptc Therapeutics, Inc. | Inhibitors of nlrp3 |
Family Cites Families (66)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5767144A (en) | 1994-08-19 | 1998-06-16 | Abbott Laboratories | Endothelin antagonists |
US6114334A (en) | 1995-07-13 | 2000-09-05 | Knoll Aktiengesellschaft | Piperazine derivatives as therapeutic agents |
DZ3262A1 (fr) | 1999-06-10 | 2000-12-12 | Warner Lambert Co | Procede d'inhibition d'agregation de proteines amyloides et d'imagerie de depots amyloides au moyen de derives d'isoindoline |
CA2406383A1 (en) | 2000-04-13 | 2001-10-25 | Mayo Foundation For Medical Education And Research | A.beta.42 lowering agents |
WO2001087845A2 (en) | 2000-05-15 | 2001-11-22 | Fujisawa Pharmaceutical Co., Ltd. | N-containing heterocyclic compounds and their use as 5-ht antagonists |
DE10109867A1 (de) | 2001-03-01 | 2002-09-05 | Abbott Gmbh & Co Kg | Verwendung von Triazolverbindungen zur Prophylaxe und Therapie neurodegenerativer Erkrankungen, Hirntrauma und zerebraler Ischämie |
DE10238002A1 (de) | 2002-08-20 | 2004-03-04 | Merck Patent Gmbh | Benzimidazolderivate |
JP2006506352A (ja) * | 2002-09-11 | 2006-02-23 | メルク エンド カムパニー インコーポレーテッド | Hivインテグラーゼ阻害剤として有用なジヒドロキシピリドピラジン−1,6−ジオン化合物 |
EP1599472A1 (en) | 2003-02-27 | 2005-11-30 | F. Hoffmann-La Roche Ag | Ccr-3 receptor antagonists |
BRPI0410348A (pt) | 2003-05-14 | 2006-05-30 | Torreypines Therapeutics Inc | compostos e usos dos mesmos na modulação de amilóide-beta |
ATE456558T1 (de) | 2003-08-14 | 2010-02-15 | Hoffmann La Roche | Gabanerge modulatoren |
DE602005023965D1 (de) | 2004-03-08 | 2010-11-18 | Prosidion Ltd | Pyrrolopyridin-2-carbonsäurehydrazide als inhibitoren von glykogenphosphorylase |
MY149038A (en) | 2004-05-26 | 2013-07-15 | Eisai R&D Man Co Ltd | Cinnamide compound |
JPWO2006046575A1 (ja) | 2004-10-26 | 2008-05-22 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | シンナミド化合物の非晶質体 |
CN101142194B (zh) | 2005-03-14 | 2012-10-10 | 顶点制药有限责任公司 | 吲哚衍生物,组合物及用作β-分泌酶抑制剂的方法 |
US7572807B2 (en) | 2005-06-09 | 2009-08-11 | Bristol-Myers Squibb Company | Heteroaryl 11-beta-hydroxysteroid dehydrogenase type I inhibitors |
US20070078136A1 (en) | 2005-09-22 | 2007-04-05 | Bristol-Myers Squibb Company | Fused heterocyclic compounds useful as kinase modulators |
EP1931620A1 (en) | 2005-09-22 | 2008-06-18 | Sanofi-Aventis | Amino-alkyl-amide derivatives as ccr3 receptor liquids |
WO2007043786A1 (en) | 2005-10-10 | 2007-04-19 | Seiyang Yang | Dynamic-based verification apparatus for verification from electronic system level to gate level, and verification method using the same |
WO2007044895A2 (en) | 2005-10-11 | 2007-04-19 | Chemtura Corporation | Diaromatic amines |
RU2008122967A (ru) | 2005-11-10 | 2009-12-20 | Шеринг Корпорейшн (US) | Имидазопиразины в качестве ингибиторов протеинкиназ |
CA2643796A1 (en) | 2006-03-09 | 2007-09-13 | Eisai R & D Management Co., Ltd. | Polycyclic cinnamide derivatives |
JP2009539762A (ja) * | 2006-03-13 | 2009-11-19 | ファイザー・プロダクツ・インク | H3受容体のテトラリン拮抗薬 |
GB0606774D0 (en) | 2006-04-03 | 2006-05-10 | Novartis Ag | Organic compounds |
US7893058B2 (en) | 2006-05-15 | 2011-02-22 | Janssen Pharmaceutica Nv | Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases |
JP2010511019A (ja) | 2006-12-01 | 2010-04-08 | ガラパゴス・ナムローゼ・フェンノートシャップ | 変性疾患及び炎症性疾患の治療に有用なイミダゾロピリジン化合物 |
EP2061771A1 (en) | 2006-12-12 | 2009-05-27 | Schering Corporation | Aspartyl protease inhibitors containing a tricyclic ring system |
CN101631786A (zh) | 2006-12-20 | 2010-01-20 | 先灵公司 | 新颖的jnk抑制剂 |
US8183276B2 (en) | 2007-02-08 | 2012-05-22 | Christian Fischer | Therapeutic agents |
EP2121633A2 (en) | 2007-02-12 | 2009-11-25 | Merck & Co., Inc. | Piperazine derivatives for treatment of ad and related conditions |
JP2010518083A (ja) | 2007-02-12 | 2010-05-27 | メルク・シャープ・エンド・ドーム・コーポレイション | ピペリジン誘導体 |
EP2155737A1 (en) | 2007-05-07 | 2010-02-24 | Schering Corporation | Gamma secretase modulators |
KR101138045B1 (ko) | 2007-05-11 | 2012-04-24 | 에프. 호프만-라 로슈 아게 | 아밀로이드 베타에 대한 조절제로서의 헤트아릴아닐린 |
US8242150B2 (en) | 2007-06-13 | 2012-08-14 | Merck Sharp & Dohme Corp. | Triazole derivatives for treating alzheimer'S disease and related conditions |
CA2692253A1 (en) | 2007-06-29 | 2009-01-08 | Schering Corporation | Gamma secretase modulators |
US7935815B2 (en) | 2007-08-31 | 2011-05-03 | Eisai R&D Management Co., Ltd. | Imidazoyl pyridine compounds and salts thereof |
CL2008002542A1 (es) | 2007-08-31 | 2009-01-02 | Eisai R&D Man Co Ltd | Compuestos derivados de imidazolil piridina ligados a un heterociclo mediante un vinilo, moduladores de la actividad de amiloide-beta; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento de enfermedades tales como alzheimer, demencia, sindrome de down o amiloidosis. |
JP2010538068A (ja) | 2007-09-06 | 2010-12-09 | シェーリング コーポレイション | ガンマセクレターゼモジュレーター |
GB0720444D0 (en) | 2007-10-18 | 2007-11-28 | Glaxo Group Ltd | Novel compounds |
MX2010006243A (es) | 2007-12-06 | 2010-08-31 | Schering Corp | Moduladores de gamma secretasa. |
MX2010006378A (es) | 2007-12-11 | 2010-09-07 | Schering Corp | Moduladores de gamma secretasa. |
CN101952275B (zh) | 2008-02-22 | 2014-06-18 | 弗·哈夫曼-拉罗切有限公司 | β-淀粉样蛋白的调节剂 |
US20100137320A1 (en) * | 2008-02-29 | 2010-06-03 | Schering Corporation | Gamma secretase modulators |
RU2560153C2 (ru) | 2008-06-20 | 2015-08-20 | Дженентек, Инк. | Триазолпиридиновые соединения, ингибирующие jak, и способы |
WO2010010188A1 (en) | 2008-07-25 | 2010-01-28 | Galapagos Nv | Novel compounds useful for the treatment of degenerative and inflammatory diseases. |
EP2356115A1 (en) | 2008-11-06 | 2011-08-17 | Schering Corporation | Gamma secretase modulators |
EP2355817A1 (en) | 2008-11-10 | 2011-08-17 | F. Hoffmann-La Roche AG | Heterocyclic gamma secretase modulators |
EP2367817A4 (en) | 2008-12-03 | 2012-05-09 | Via Pharmaceuticals Inc | INHIBITORS OF DIACYLGLYCEROL ACYLTRANSFERASE ENZYME |
PA8854101A1 (es) * | 2008-12-18 | 2010-07-27 | Ortho Mcneil Janssen Pharm | Derivados de imidazol bicíclicos sustituidos como moduladores de gamma secretasa |
TW201030002A (en) | 2009-01-16 | 2010-08-16 | Bristol Myers Squibb Co | Bicyclic compounds for the reduction of beta-amyloid production |
CN102325765B (zh) | 2009-02-06 | 2014-12-24 | 杨森制药公司 | 作为γ-分泌酶调节剂的取代的双环杂环化合物 |
TWI461425B (zh) | 2009-02-19 | 2014-11-21 | Janssen Pharmaceuticals Inc | 作為伽瑪分泌酶調節劑之新穎經取代的苯并唑、苯并咪唑、唑并吡啶及咪唑并吡啶衍生物類 |
JP2012051807A (ja) | 2009-02-26 | 2012-03-15 | Eisai R & D Management Co Ltd | アリールイミダゾール化合物 |
EP2401276B1 (en) | 2009-02-26 | 2013-06-05 | Eisai R&D Management Co., Ltd. | Nitrogen-containing fused heterocyclic compounds and their use as beta amyloid production inhibitors |
JP2012051806A (ja) | 2009-02-26 | 2012-03-15 | Eisai R & D Management Co Ltd | イミダゾリルピラジン誘導体 |
US20120053165A1 (en) | 2009-03-03 | 2012-03-01 | Pfizer Inc. | Novel Phenyl Imidazoles and Phenyl Triazoles As Gamma-Secretase Modulators |
EP2410529A1 (en) | 2009-03-16 | 2012-01-25 | Panasonic Corporation | Application running device |
WO2010126745A1 (en) | 2009-04-27 | 2010-11-04 | High Point Pharmaceuticals, Llc | SUBSTITUTED IMIDAZO[1,2-A]PYRIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE AS β-SECRETASE INHIBITORS |
CN102439005B (zh) | 2009-05-07 | 2015-07-22 | 杨森制药公司 | 作为γ-分泌酶调节剂的取代的吲唑和氮杂-吲唑衍生物 |
JP2010274429A (ja) | 2009-05-26 | 2010-12-09 | Ihi Corp | アライメントステージ |
KR20120050450A (ko) | 2009-07-15 | 2012-05-18 | 얀센 파마슈티칼즈, 인코포레이티드 | 감마 세크레타제 조절제로서의 치환된 트리아졸 및 이미다졸 유도체 |
US9145399B2 (en) | 2010-01-15 | 2015-09-29 | Janssen Pharmaceuticals, Inc. | Substituted bicyclic triazole derivatives as gamma secretase modulators |
AU2012230348A1 (en) | 2011-03-24 | 2013-08-29 | Cellzome Limited | Novel substituted triazolyl piperazine and triazolyl piperidine derivatives as gamma secretase modulators |
ES2602794T3 (es) | 2011-03-31 | 2017-02-22 | Pfizer Inc | Piridinonas bicíclicas novedosas |
IN2014MN00258A (pt) | 2011-07-15 | 2015-09-25 | Janssen Pharmaceuticals Inc | |
JP6106745B2 (ja) * | 2012-05-16 | 2017-04-05 | ヤンセン ファーマシューティカルズ,インコーポレーテッド | (特に)アルツハイマー病の治療に有用な置換3,4−ジヒドロ−2H−ピリド[1,2−a]ピラジン−1,6−ジオン誘導体 |
-
2013
- 2013-05-16 JP JP2015512188A patent/JP6106745B2/ja active Active
- 2013-05-16 SG SG11201407051XA patent/SG11201407051XA/en unknown
- 2013-05-16 ES ES13730364.0T patent/ES2585009T3/es active Active
- 2013-05-16 KR KR1020147032211A patent/KR102096625B1/ko active IP Right Grant
- 2013-05-16 AU AU2013261023A patent/AU2013261023B2/en active Active
- 2013-05-16 BR BR112014028395-8A patent/BR112014028395B1/pt active IP Right Grant
- 2013-05-16 WO PCT/IB2013/054014 patent/WO2013171712A1/en active Application Filing
- 2013-05-16 MX MX2014013957A patent/MX355164B/es active IP Right Grant
- 2013-05-16 NZ NZ702611A patent/NZ702611A/en unknown
- 2013-05-16 CN CN201380025320.6A patent/CN104583208B/zh active Active
- 2013-05-16 CA CA2870347A patent/CA2870347C/en active Active
- 2013-05-16 EA EA201492112A patent/EA027242B1/ru not_active IP Right Cessation
- 2013-05-16 US US14/400,663 patent/US9181245B2/en active Active
- 2013-05-16 EP EP13730364.0A patent/EP2850083B1/en active Active
-
2014
- 2014-11-12 IL IL235659A patent/IL235659A/en active IP Right Grant
-
2015
- 2015-08-28 HK HK15108363.5A patent/HK1207645A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
AU2013261023B2 (en) | 2016-11-24 |
JP6106745B2 (ja) | 2017-04-05 |
HK1207645A1 (en) | 2016-02-05 |
IL235659A0 (en) | 2015-02-01 |
JP2015517517A (ja) | 2015-06-22 |
CA2870347C (en) | 2020-08-04 |
EA201492112A1 (ru) | 2015-04-30 |
CA2870347A1 (en) | 2013-11-21 |
EP2850083B1 (en) | 2016-04-27 |
IL235659A (en) | 2017-02-28 |
CN104583208A (zh) | 2015-04-29 |
KR20150009548A (ko) | 2015-01-26 |
BR112014028395B1 (pt) | 2022-02-01 |
EP2850083A1 (en) | 2015-03-25 |
KR102096625B1 (ko) | 2020-04-03 |
EA027242B1 (ru) | 2017-07-31 |
AU2013261023A1 (en) | 2014-10-30 |
WO2013171712A1 (en) | 2013-11-21 |
NZ702611A (en) | 2016-10-28 |
SG11201407051XA (en) | 2014-11-27 |
MX2014013957A (es) | 2015-02-12 |
MX355164B (es) | 2018-04-06 |
CN104583208B (zh) | 2016-09-28 |
US20150141411A1 (en) | 2015-05-21 |
ES2585009T3 (es) | 2016-10-03 |
US9181245B2 (en) | 2015-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112014028395A2 (pt) | derivados 3,4-di-hidro-2h-pirido[1,2-a] pirazina-1,6-diona substituídos úteis para o tratamento de (inter alia) doença de alzheimer | |
IL274771A (en) | Use of pyrazolopyrimidine derivatives for the treatment of PI3Kδ associated disorders | |
DK3418281T3 (da) | Pyrazolo[1,5-a]pyrimidiner, der er anvendelige som inhibitorer af atr-kinase til behandling af cancersygdomme | |
HRP20182007T1 (hr) | Derivati 3-okso-2,3,5,8-tetrahidro-[1,2,4]triazolo[4,3-a]pirimidina za liječenje respiratornih bolesti | |
BR112013021366A2 (pt) | imidazo[5,1-f][1,2,4]triazinas para o tratamento de desordens neurológicas | |
CO7061081A2 (es) | Derivados macrocíclicos para el tratamiento de enfermedades | |
DK3489238T3 (da) | Farmaceutiske sammensætninger af 6h-pyrido[3,2-e][1,2,4]triazolo[1,5-c]pyrimidin-5-on- og [1,2,4]triazolo[1,5-c]pteridin-5(6h)-on-derivater som pde1-inhibitorer til behandling af for eksempel neurologiske lidelser | |
SI2776442T1 (sl) | Derivati (1,2,3)triazolo(4,5-d)pirimidina kot agonisti kanabinoidnega receptorja 2 | |
CL2015000408A1 (es) | Compuestos derivados de pirazolo[4,3-d]pirimidina y sus sales; composicion farmaceutica que los comprende, util para el tratamiento de enfermedades alergicas, inflamatorias, infecciosas o cancer. | |
IL243092B (en) | New triazolo[d–4,5]pyrimidine histories | |
ZA201403441B (en) | [1,2,3]triazolo[4,5-d]pyrimidine derivatives as agonists of the cannabinoid | |
CL2014002847A1 (es) | Compuestos triazolo derivados, inhibidores de pde10; procedimiento de preparacion; uso para el tratamiento y/o profilaxis de trastornos psicoticos, esquizofrenia, ansiedad, adicciona a drogas, enfermedad de parkinson, entre otras. | |
HRP20182021T1 (hr) | Derivati [1,2,4]triazolo[1,5-a]pirimidina kao inhibitori proteazoma protozoe za liječenje parazitskih bolesti poput lišmenijaze | |
HK1208454A1 (zh) | 治療細菌性疾病的嘧啶衍生物 | |
TWI841376B (zh) | 吡唑并嘧啶衍生物治療PI3Kδ相關病症之用途 | |
TH1601003657A (th) | อนุพันธ์ [1,2,4] ไตรอะโซโล [1,5-a]ไพริมิดีน ดังสารยับยั้งโปรเตียโซมของ โปรโตซัวสำหรับการรักษาของโรคที่เกิดจากปรสิต เช่น โรคลิชมาเนียซิส |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 16/05/2013, OBSERVADAS AS CONDICOES LEGAIS. |